Somalwar’s Nikalas Mahila Mahavidyalaya, Nagpur in collaboration with Mahatma Gandhi Institute For Rural Industrialization, Wardha had organized National Symposium on Natural Cosmetics: Innovation & Trends on 5th January 2016. It was inaugurated by lightening traditional lamp by Dr.P.G.Yeole, Pro Vice Chancellor, RTM Nagpur University, Dr.Prafull Kale, Director-MGIRI, Dr.Seema Somalwar-Principal, Nikalas Mahila Mahavidyalaya, Advocate Shri Madhukarrao Somalwar, President, Somalwar Education Society, Vinay Kumar Singh-General Manager, Mikasa Cosmetics Limited, Dr. Sheela Kulkarni-HOD, LAD College.
Merck, known as MSD outside the United States and Canada, announced that it has acquired IOmet, a privately-held UK-based drug discovery company focused on the development of innovative medicines for the treatment of cancer, with a particular emphasis on the fields of cancer immunotherapy and cancer metabolism. Under terms of the agreement, Merck, through a subsidiary, will acquire IOmet, including its comprehensive pre-clinical pipeline of IDO (indoleamine-2,3-dioxygenase 1), TDO (tryptophan-2,3-dioxygenase), and dual-acting IDO/TDO inhibitors. Based on the transaction, IOmet will become a wholly owned subsidiary of Merck.